cannabis
- Home
- cannabis
Public
Research Note - Rise of the Cashless Economy
- Review
- June 3, 2020
Novatti launches new payments platform for purpose-issued Visa cards
- Review
- September 29, 2020
Is this the most hated company on the ASX?
- Review
- August 16, 2019
Latest Articles
Little Green Pharma approved to commence manufacturing cannabis products
Australian cannabis company Little Green Pharma (ASX: LGP) has reached a major commercial achievement in their long-term strategy having been granted a manufacturing licence for cannabis products at their newly commissioned facility in Western Australia. “The grant represents the culmination of LGP’s long-term regulatory strategy and is a clear watershed moment for the Company. The
Read MorePublic
A new world beckons for the listed medical cannabis stocks, but liberalisation is not what it seems
Having been subject to a harsh reality check over the last year or so, the ASX listed cannabis sector is applauding the local medicine regulator’s endorsement of the weed as an effective therapy that should be more freely available to the ailing masses. But the path to the pharmacy is likely to be harder than
Read MorePublic
AusCann success with medicinal cannabis for nerve pain trials
Pharmaceuticals company AusCann (ASX: AC8) is set to progress to the next stage of clinical trials having successfully completed their first round on Neuvis, their cannabinoid-based capsule developed to treat nerve pain – an area of medicine that is inadequately met. Estimated to affect 7-10% of Australians, nerve pain is caused by damage to the
Read MorePublic
Cannabis stocks rise as TGA to approve over-the-counter CBD without prescription
Despite a gloomy day on the ASX yesterday, Australian cannabis companies ended it very well upon news of the Therapeutic Goods Association (TGA) announcing they will amend legislation that will open a clear path for Australians to purchase cannabidiol (CBD) products without a prescription. The notice of interim decision was released confirming that the TGA
Read MorePublic
Althea’s cannabis clinics join national referrals network, telehealth booming
Global pharmaceutics and cannabis healthcare company Althea Group (ASX: AGH) has harnessed the power of telehealth through COVID-19, almost doubling web-based enquiries for their MyAccess Clinics in the UK where patients can seek medicinal cannabis treatment pathways. With the England being one of the harder nations hit by COVID-19, Althea accelerated telehealth offerings for its
Read MorePublic
Top cannabis grower enters production deal with THC Global
In preparation for legislative changes which may soon see cannabis products purchasable over the counter without a prescription, leading medicinal cannabis product manufacturer THC Global (ASX: THC) has partnered with Cannatrek to produce white-labeled CBD products at their high-volume Southport facility in Queensland. As a sizable grower of medicinal cannabis with a diverse range of
Read MorePublic